37
Janus Henderson Biotech Innovation Fund II Access raises $155M as hedge fund with 610 investors
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $155M · NEW YORK, NY · filed 2026-10-13
3(c)(7) — qualified purchasers
82
Janus Henderson launches Ascent Crossover Opportunity Fund III Follow-On Vehicle
New fund · Opportunistic / special situations · Pre-first close · WILMINGTON, DE · Form D filed 2026-10-23 · sponsor: Janus Henderson
Janus Henderson Investors US LLC is raising an indefinite-size opportunistic fund through Ascent Crossover Opportunity Fund III Follow-On Vehicle, L.P., a Delaware limited partnership. The fund is structured for institutional and qualified-purchaser investors under Regulation D exemption 3(c)(7) and has not yet closed its first sale.
3(c)(7) — qualified purchasersPre-first closeFirst filing by this entityrepeat_fund_numeralPlacement agent engagedOpportunistic / special situations
Why now — by persona
- Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund-formation counsel:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| n/a Janus Henderson Investors US LLC | Investment Manager of the Issuer |
| n/a Ascent Crossover Opportunity Fund III Follow-On Vehicle GP, LLC | General Partner of the Issuer |
| Dave Sherwin | Director |
| Paolo Villasenor | Director |
| Vincent Merry | Director |
Signed by Linda Ruan, Compliance Officer.
Placement agents / sales compensation: Janus Henderson Distributors US LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.